pharma · Dengue Fever · Chronic Babesiosis · SXTP
60 DEGREES PHARMACEUTICALS
60 DEGREES PHARMACEUTICALS, INC.
60 Degrees Pharmaceuticals is a pharma organization headquartered in Washington, USA. It trades on NYSE under ticker SXTP. Primary therapeutic focus areas include Dengue Fever, Chronic Babesiosis, Babesiosis, COVID 19 Di
Washington, USA HQ
2010 Founded
6 Employees
Public company Type
SXTP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Washington, USA
- Founded
- 2010
- Employees
- 6
- Programs
- 5
- Drugs
- 2
- Patents
- 0
Tafenoquine Oral Tablet
Phase 2 · small molecule · COVID 19 Disease
Tafenoquine Oral Tablet for COVID 19 Disease is a Phase 2 program (small_molecule) at 60 DEGREES PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Internal code TQ 2020_06
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- 60 DEGREES PHARMACEUTICALS, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- COVID 19 Disease
- Status
- completed
- Trials
- 1